Pre-mRNA splicing: Role of epigenetics and implications in disease

Advances in Biological Regulation

Volumn 52, Issue 3, 2012, Pages 377-388

  Khan, Dilshad H ^a   Jahan, Sanzida ^a   Davie, James R ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

EID: 84864553255     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2012.04.003     Document Type: Review

References (121)

1. de Almeida S.F., Grosso A.R., Koch F., Fenouil R., Carvalho S., Andrade J., et al. Splicing enhances recruitment of methyltransferase HYPB/Setd2 and methylation of histone H3 Lys36. Nature Structural & Molecular Biology 2011, 18:977-983.
2. Anczukow O., Rosenberg A.Z., Akerman M., Das S., Zhan L., Karni R., et al. The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nature Structural & Molecular Biology 2012, 19:220-228.
3. Andersson R., Enroth S., Rada-Iglesias A., Wadelius C., Komorowski J. Nucleosomes are well positioned in exons and carry characteristic histone modifications. Genome Research 2009, 19:1732-1741.
4. Bae J., Leo C.P., Hsu S.Y., Hsueh A.J. MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain. Journal of Biological Chemistry 2000, 275:25255-25261.
5. Barash Y., Calarco J.A., Gao W., Pan Q., Wang X., Shai O., et al. Deciphering the splicing code. Nature 2010, 465:53-59.
6. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., et al. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
7. Batsche E., Yaniv M., Muchardt C. The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nature Structural & Molecular Biology 2006, 13:22-29.
8. Bingle C.D., Craig R.W., Swales B.M., Singleton V., Zhou P., Whyte M.K. Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death. Journal of Biological Chemistry 2000, 275:22136-22146.
9. Black D.L. Mechanisms of alternative pre-messenger RNA splicing. Annual Review of Biochemistry 2003, 72:291-336.
10. Brody Y., Shav-Tal Y. Transcription and splicing: when the twain meet. Transcription 2011, 2:216-220.
11. Carrillo O.F., Bieberstein N., Neugebauer K.M. Pause locally, splice globally. Trends in Cell Biology 2011, 21:328-335.
12. Cartegni L., Chew S.L., Krainer A.R. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nature Reviews Genetics 2002, 3:285-298.
13. Chalfant C.E., Rathman K., Pinkerman R.L., Wood R.E., Obeid L.M., Ogretmen B., et al. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. Journal of Biological Chemistry 2002, 277:12587-12595.
14. Chen-Cleland T.A., Boffa L.C., Carpaneto E.M., Mariani M.R., Valentin E., Mendez E., et al. Recovery of transcriptionally active chromatin restriction fragments by binding to organomercurial-agarose magnetic beads. A rapid and sensitive method for monitoring changes in higher order chromatin structure during gene activation and repression. Journal of Biological Chemistry 1993, 268:23409-23416.
15. Cheng D., Cote J., Shaaban S., Bedford M.T. The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. Molecular Cell 2007, 25:71-83.
16. Cho S., Hoang A., Chakrabarti S., Huynh N., Huang D.B., Ghosh G. The SRSF1 linker induces semi-conservative ESE binding by cooperating with the RRMs. Nucleic Acids Research 2011, 39:9413-9421.
17. Chodavarapu R.K., Feng S., Bernatavichute Y.V., Chen P.Y., Stroud H., Yu Y., et al. Relationship between nucleosome positioning and DNA methylation. Nature 2010, 466:388-392.
18. Conaway R.C., Conaway J.W. Function and regulation of the mediator complex. Current Opinion in Genetics & Development 2011, 21:225-230.
19. Czarnota G.J., Bazett-Jones D.P., Mendez E., Allfrey V.G., Ottensmeyer F.P. High resolution microanalysis and three-dimensional nucleosome structure associated with transcribing chromatin. Micron 1997, 28:419-431.
20. Dhami P., Saffrey P., Bruce A.W., Dillon S.C., Chiang K., Bonhoure N., et al. Complex exon-intron marking by histone modifications is not determined solely by nucleosome distribution. PLoS ONE 2010, 5:e12339.
21. Dominissini D., Moshitch-Moshkovitz S., Amariglio N., Rechavi G. Adenosine-to-inosine RNA editing meets cancer. Carcinogenesis 2011, 32:1569-1577.
22. Doyon Y., Selleck W., Lane W.S., Tan S., Cote J. Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans. Molecular and Cell Biology 2004, 24:1884-1896.
23. Dredge B.K., Polydorides A.D., Darnell R.B. The splice of life: alternative splicing and neurological disease. Nature Reviews Neuroscience 2001, 2:43-50.
24. Edmunds J.W., Mahadevan L.C., Clayton A.L. Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. EMBO Journal 2008, 27:406-420.
25. Egloff S., Murphy S. Cracking the RNA polymerase II CTD code. Trends in Genetics 2008, 24:280-288.
26. Ezponda T., Pajares M.J., Agorreta J., Echeveste J.I., Lopez-Picazo J.M., Torre W., et al. The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression. Clinical Cancer Research 2010, 16:4113-4125.
27. Faustino N.A., Cooper T.A. Pre-mRNA splicing and human disease. Genes & Development 2003, 17:419-437.
28. Ge K., DuHadaway J., Du W., Herlyn M., Rodeck U., Prendergast G.C. Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:9689-9694.
29. Ghigna C., Moroni M., Porta C., Riva S., Biamonti G. Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Research 1998, 58:5818-5824.
30. Grabowski P.J., Black D.L. Alternative RNA splicing in the nervous system. Progress in Neurobiology 2001, 65:289-308.
31. Gunderson F.Q., Merkhofer E.C., Johnson T.L. Dynamic histone acetylation is critical for cotranscriptional spliceosome assembly and spliceosomal rearrangements. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:2004-2009.
32. He X., Arslan A.D., Pool M.D., Ho T.T., Darcy K.M., Coon J.S., et al. Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer. Oncogene 2011, 30:356-365.
33. He X., Ee P.L., Coon J.S., Beck W.T. Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20. Clinical Cancer Research 2004, 10:4652-4660.
34. He X., Pool M., Darcy K.M., Lim S.B., Auersperg N., Coon J.S., et al. Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Oncogene 2007, 26:4961-4968.
35. Hnilicova J., Hozeifi S., Duskova E., Icha J., Tomankova T., Stanek D. Histone deacetylase activity modulates alternative splicing. PLoS ONE 2011, 6:e16727.
36. Hnilicova J., Stanek D. Where splicing joins chromatin. Nucleus 2011, 2:182-188.
37. Hodges E., Smith A.D., Kendall J., Xuan Z., Ravi K., Rooks M., et al. High definition profiling of mammalian DNA methylation by array capture and single molecule bisulfite sequencing. Genome Research 2009, 19:1593-1605.
38. Huang C.S., Shen C.Y., Wang H.W., Wu P.E., Cheng C.W. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer. Clinica Chimica Acta 2007, 384:69-74.
39. Huang Y., Gattoni R., Stevenin J., Steitz J.A. SR splicing factors serve as adapter proteins for TAP-dependent mRNA export. Molecular Cell 2003, 11:837-843.
40. Huang Y., Li W., Yao X., Lin Q.J., Yin J.W., Liang Y., et al. Mediator complex regulates alternative mRNA processing via the MED23 subunit. Molecular Cell 2012, 45:459-469.
41. Huff J.T., Plocik A.M., Guthrie C., Yamamoto K.R. Reciprocal intronic and exonic histone modification regions in humans. Nature Structural & Molecular Biology 2010, 17:1495-1499.
42. Ip J.Y., Schmidt D., Pan Q., Ramani A.K., Fraser A.G., Odom D.T., et al. Global impact of RNA polymerase II elongation inhibition on alternative splicing regulation. Genome Research 2011, 21:390-401.
43. Irimia M., Blencowe B.J. Alternative splicing: decoding an expansive regulatory layer. Current Opinion in Cell Biology 2012.
44. Jang B.I., Li Y., Graham D.Y., Cen P. The role of CD44 in the pathogenesis, diagnosis, and therapy of gastric cancer. Gut and Liver 2011, 5:397-405.
45. Jia R., Li C., McCoy J.P., Deng C.X., Zheng Z.M. SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance. International Journal of Biological Sciences 2010, 6:806-826.
46. Johnson J.M., Castle J., Garrett-Engele P., Kan Z., Loerch P.M., Armour C.D., et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 2003, 302:2141-2144.
47. Kalsotra A., Cooper T.A. Functional consequences of developmentally regulated alternative splicing. Nature Reviews Genetics 2011, 12:715-729.
48. Kanopka A., Muhlemann O., Akusjarvi G. Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature 1996, 381:535-538.
49. Karni R., de Stanchina E., Lowe S.W., Sinha R., Mu D., Krainer A.R. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nature Structural & Molecular Biology 2007, 14:185-193.
50. Karni R., Hippo Y., Lowe S.W., Krainer A.R. The splicing-factor oncoprotein SF2/ASF activates mTORC1. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:15323-15327.
51. Kim S., Kim H., Fong N., Erickson B., Bentley D.L. Pre-mRNA splicing is a determinant of histone H3K36 methylation. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:13564-13569.
52. Kolasinska-Zwierz P., Down T., Latorre I., Liu T., Liu X.S., Ahringer J. Differential chromatin marking of introns and expressed exons by H3K36me3. Nature Genetics 2009, 41:376-381.
53. Kornblihtt A.R., de la M.M., Fededa J.P., Munoz M.J., Nogues G. Multiple links between transcription and splicing. RNA 2004, 10:1489-1498.
54. Kuhn A.N., van Santen M.A., Schwienhorst A., Urlaub H., Luhrmann R. Stalling of spliceosome assembly at distinct stages by small-molecule inhibitors of protein acetylation and deacetylation. RNA 2009, 15:153-175.
55. Kuhn P., Chumanov R., Wang Y., Ge Y., Burgess R.R., Xu W. Automethylation of CARM1 allows coupling of transcription and mRNA splicing. Nucleic Acids Research 2011, 39:2717-2726.
56. Kwon S.H., Florens L., Swanson S.K., Washburn M.P., Abmayr S.M., Workman J.L. Heterochromatin protein 1 (HP1) connects the FACT histone chaperone complex to the phosphorylated CTD of RNA polymerase II. Genes & Development 2010, 24:2133-2145.
57. Kwon S.H., Workman J.L. HP1c casts light on dark matter. Cell Cycle 2011, 10:625-630.
58. Kwon S.H., Workman J.L. The changing faces of HP1: from heterochromatin formation and gene silencing to euchromatic gene expression: HP1 acts as a positive regulator of transcription. BioEssays 2011, 33:280-289.
59. Leff S.E., Rosenfeld M.G., Evans R.M. Complex transcriptional units: diversity in gene expression by alternative RNA processing. Annual Review of Biochemistry 1986, 55:1091-1117.
60. Li X., Manley J.L. Alternative splicing and control of apoptotic DNA fragmentation. Cell Cycle 2006, 5:1286-1288.
61. Locklear L.J., Ridsdale J.A., Bazett Jones D.P., Davie J.R. Ultrastructure of transcriptionally competent chromatin. Nucleic Acids Research 1990, 18:7015-7024.
62. Luco R.F., Allo M., Schor I.E., Kornblihtt A.R., Misteli T. Epigenetics in alternative pre-mRNA splicing. Cell 2011, 144:16-26.
63. Luco R.F., Misteli T. More than a splicing code: integrating the role of RNA, chromatin and non-coding RNA in alternative splicing regulation. Current Opinion in Genetics & Development 2011, 21:366-372.
64. Luco R.F., Pan Q., Tominaga K., Blencowe B.J., Pereira-Smith O.M., Misteli T. Regulation of alternative splicing by histone modifications. Science 2010, 327:996-1000.
65. Maas S. Posttranscriptional recoding by RNA editing. Advances in Protein Chemistry and Structural Biology 2012, 86:193-224.
66. Maas S., Patt S., Schrey M., Rich A. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:14687-14692.
67. Manley J.L., Krainer A.R. A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). Genes & Development 2010, 24:1073-1074.
68. Martinez N.M., Pan Q., Cole B.S., Yarosh C.A., Babcock G.A., Heyd F., et al. Alternative splicing networks regulated by signaling in human T cells. RNA 2012.
69. de la Mata M., Alonso C.R., Kadener S., Fededa J.P., Blaustein M., Pelisch F., et al. A slow RNA polymerase II affects alternative splicing in vivo. Molecular Cell 2003, 12:525-532.
70. Michlewski G., Sanford J.R., Caceres J.F. The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1. Molecular Cell 2008, 30:179-189.
71. Mooney S.M., Goel A., D'Assoro A.B., Salisbury J.L., Janknecht R. Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase. Journal of Biological Chemistry 2010, 285:30443-30452.
72. Moore M.J., Wang Q., Kennedy C.J., Silver P.A. An alternative splicing network links cell-cycle control to apoptosis. Cell 2010, 142:625-636.
73. Mukherji M., Brill L.M., Ficarro S.B., Hampton G.M., Schultz P.G. A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways. Biochemistry 2006, 45:15529-15540.
74. Munoz M.J., de la M.M., Kornblihtt A.R. The carboxy terminal domain of RNA polymerase II and alternative splicing. Trends in Biochemical Sciences 2010, 35:497-504.
75. Nahkuri S., Taft R.J., Mattick J.S. Nucleosomes are preferentially positioned at exons in somatic and sperm cells. Cell Cycle 2009, 8:3420-3424.
76. Naor D., Nedvetzki S., Golan I., Melnik L., Faitelson Y. CD44 in cancer. Critical Reviews in Clinical Laboratory Sciences 2002, 39:527-579.
77. Olsson E., Honeth G., Bendahl P.O., Saal L.H., Gruvberger-Saal S., Ringner M., et al. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers. BMC Cancer 2011, 11:418.
78. Osorio F.G., Navarro C.L., Cadinanos J., Lopez-Mejia I.C., Quiros P.M., Bartoli C., et al. Splicing-directed therapy in a new mouse model of human accelerated aging. Science Translational Medicine 2011, 3. 106ra107.
79. Palusa S.G., Ali G.S., Reddy A.S. Alternative splicing of pre-mRNAs of Arabidopsis serine/arginine-rich proteins: regulation by hormones and stresses. Plant Journal 2007, 49:1091-1107.
80. Pedraza-Farina L.G. Mechanisms of oncogenic cooperation in cancer initiation and metastasis. Yale Journal of Biology and Medicine 2006, 79:95-103.
81. Pick M., Flores-Flores C., Soreq H. From brain to blood: alternative splicing evidence for the cholinergic basis of Mammalian stress responses. Annals of the New York Academy of Sciences 2004, 1018:85-98.
82. Pind M.T., Watson P.H. SR protein expression and CD44 splicing pattern in human breast tumours. Breast Cancer Research and Treatment 2003, 79:75-82.
83. Porensky P.N., Mitrpant C., McGovern V.L., Bevan A.K., Foust K.D., Kaspar B.K., et al. A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Human Molecular Genetics 2011.
84. Quesada V., Conde L., Villamor N., Ordonez G.R., Jares P., Bassaganyas L., et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nature Genetics 2011, 44:47-52.
85. Rappsilber J., Ryder U., Lamond A.I., Mann M. Large-scale proteomic analysis of the human spliceosome. Genome Research 2002, 12:1231-1245.
86. Riessland M., Ackermann B., Forster A., Jakubik M., Hauke J., Garbes L., et al. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Human Molecular Genetics 2010, 19:1492-1506.
87. Ritchie D.B., Schellenberg M.J., MacMillan A.M. Spliceosome structure: piece by piece. Biochimica et Biophysica Acta 2009, 1789:624-633.
88. Saint-Andre V., Batsche E., Rachez C., Muchardt C. Histone H3 lysine 9 trimethylation and HP1gamma favor inclusion of alternative exons. Nature Structural & Molecular Biology 2011, 18:337-344.
89. Sanford J.R., Wang X., Mort M., Vanduyn N., Cooper D.N., Mooney S.D., et al. Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts. Genome Research 2009, 19:381-394.
90. Schor I.E., Rascovan N., Pelisch F., Allo M., Kornblihtt A.R. Neuronal cell depolarization induces intragenic chromatin modifications affecting NCAM alternative splicing. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:4325-4330.
91. Schwartz S., Ast G. Chromatin density and splicing destiny: on the cross-talk between chromatin structure and splicing. EMBO Journal 2010, 29:1629-1636.
92. Schwartz S., Meshorer E., Ast G. Chromatin organization marks exon-intron structure. Nature Structural & Molecular Biology 2009, 16:990-995.
93. Shepard P.J., Hertel K.J. The SR protein family. Genome Biology 2009, 10:242.
94. Shieh J.J., Liu K.T., Huang S.W., Chen Y.J., Hsieh T.Y. Modification of alternative splicing of Mcl-1 pre-mRNA using antisense morpholino oligonucleotides induces apoptosis in basal cell carcinoma cells. Journal of Investigative Dermatology 2009, 129:2497-2506.
95. Shukla S., Oberdoerffer S. Co-transcriptional regulation of alternative pre-mRNA splicing. Biochimica et Biophysica Acta 2012.
96. Sims R.J., Millhouse S., Chen C.F., Lewis B.A., Erdjument-Bromage H., Tempst P., et al. Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Molecular Cell 2007, 28:665-676.
97. Sinclair C.S., Rowley M., Naderi A., Couch F.J. The 17q23 amplicon and breast cancer. Breast Cancer Research and Treatment 2003, 78:313-322.
98. Spaeth J.M., Kim N.H., Boyer T.G. Mediator and human disease. Seminars in Cell & Developmental Biology 2011, 22:776-787.
99. Sperling J., Azubel M., Sperling R. Structure and function of the Pre-mRNA splicing machine. Structure 2008, 16:1605-1615.
100. Spies N., Nielsen C.B., Padgett R.A., Burge C.B. Biased chromatin signatures around polyadenylation sites and exons. Molecular Cell 2009, 36:245-254.
101. Stickeler E., Kittrell F., Medina D., Berget S.M. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 1999, 18:3574-3582.
102. Sun J.-M., Chen H.Y., Davie J.R. Isolation of transcriptionally active chromatin from human breast cancer cells using sulfolink coupling gel chromatography. Journal of Cellular Biochemistry 2002, 84:439-446.
103. Sun X.J., Wei J., Wu X.Y., Hu M., Wang L., Wang H.H., et al. Identification and characterization of a novel human histone H3 lysine 36-specific methyltransferase. Journal of Biological Chemistry 2005, 280:35261-35271.
104. Tacke R., Manley J.L. Functions of SR and Tra2 proteins in pre-mRNA splicing regulation. Proceedings of the Society for Experimental Biology and Medicine 1999, 220:59-63.
105. Taylor J.K., Zhang Q.Q., Wyatt J.R., Dean N.M. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides. Nature Biotechnology 1999, 17:1097-1100.
106. Tazi J., Bakkour N., Stamm S. Alternative splicing and disease. Biochimica et Biophysica Acta 2009, 1792:14-26.
107. Tilgner H., Nikolaou C., Althammer S., Sammeth M., Beato M., Valcarcel J., et al. Nucleosome positioning as a determinant of exon recognition. Nature Structural & Molecular Biology 2009, 16:996-1001.
108. Tyagi A., Ryme J., Brodin D., Ostlund Farrants A.K., Visa N. SWI/SNF associates with nascent pre-mRNPs and regulates alternative pre-mRNA processing. PLoS Genetics 2009, 5:e1000470.
109. Ververis K., Karagiannis T.C. Potential non-oncological applications of histone deacetylase inhibitors. American Journal of Translational Research 2011, 3:454-467.
110. Wahl M.C., Will C.L., Luhrmann R. The spliceosome: design principles of a dynamic RNP machine. Cell 2009, 136:701-718.
111. Walia H., Chen H.Y., Sun J.-M., Holth L.T., Davie J.R. Histone acetylation is required to maintain the unfolded nucleosome structure associated with transcribing DNA. Journal of Biological Chemistry 1998, 273:14516-14522.
112. Wang G.S., Cooper T.A. Splicing in disease: disruption of the splicing code and the decoding machinery. Nature Reviews Genetics 2007, 8:749-761.
113. Wang J., Zhang J., Li K., Zhao W., Cui Q. SpliceDisease database: linking RNA splicing and disease. Nucleic Acids Research 2012, 40:D1055-D1059.
114. Wang L., Lawrence M.S., Wan Y., Stojanov P., Sougnez C., Stevenson K., et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. The New England Journal of Medicine 2011, 365:2497-2506.
115. Wilson B.J., Bates G.J., Nicol S.M., Gregory D.J., Perkins N.D., Fuller-Pace F.V. The p68 and p72 DEAD box RNA helicases interact with HDAC1 and repress transcription in a promoter-specific manner. BMC Molecular Biology 2004, 5:11.
116. Witt O., Deubzer H.E., Milde T., Oehme I. HDAC family: what are the cancer relevant targets?. Cancer Letters 2009, 277:8-21.
117. Wu J.Y., Tang H., Havlioglu N. Alternative pre-mRNA splicing and regulation of programmed cell death. Progress in Molecular and Subcellular Biology 2003, 31:153-185.
118. Zaharieva E., Chipman K., Soller M. Alternative splicing interference by xenobiotics. Toxicology 2012.
119. Zhang Z., Krainer A.R. Involvement of SR proteins in mRNA surveillance. Molecular Cell 2004, 16:597-607.
120. Zhou H.L., Hinman M.N., Barron V.A., Geng C., Zhou G., Luo G., et al. Hu proteins regulate alternative splicing by inducing localized histone hyperacetylation in an RNA-dependent manner. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:E627-E635.
121. Zhou Z., Licklider L.J., Gygi S.P., Reed R. Comprehensive proteomic analysis of the human spliceosome. Nature 2002, 419:182-185.